Atrial Fibrillation Surgery Market expected worth $1.73 Billion by 2020

1. MarketsandMarkets Presents Atrial Fibrillation Surgery Market– North America to offer significant growth opportunities http://www.marketsandmarkets.com/Market-Reports/atrial-fibrillation-surgery-market-8998731.html

2. The report "Atrial Fibrillation Surgery Market by Procedure (Catheter Ablation, Surgical Ablation/Maze), Product (Catheter Ablation, Surgical Ablation), and Geography (Canada, China, France, Germany, India, Japan, U.S., U.K.) - Global Forecast to 2020", the global AF surgery product market was worth $791.5 Million in 2014 and is estimated to reach $1.73 Billion by 2020. Browse: 18 market data tables 73 Slides and in-depth TOC on "Atrial Fibrillation Surgery Market” Download The PDF Brochure@ http://www.marketsandmarkets.com/pdfdownload.asp?id=8998731 The report provides a detailed overview of the major drivers, restraints and opportunities impacting the atrial fibrillation surgery market along with estimates of revenue and competitive landscape. The types of atrial fibrillation ablation procedures within the scope of the study include catheter ablation and surgical ablation. The global atrial fibrillation surgery procedures market is expected to grow at a CAGR of 11.9% during the forecast period. http://www.marketsandmarkets.com/Market-Reports/atrial-fibrillation-surgery-market-8998731.html

3. The atrial fibrillation surgery market has immense growth potential from 2015 to 2020. The factors propelling growth in this market include increasing number of people suffering from atrial fibrillation and favorable regulations. Ask For Discount on this Report@ http://www.marketsandmarkets.com/discountreports.asp?id=8998731 About 4.4% people out of diagnosed atrial fibrillation population are treated using ablation technology in the U.S., Europe, and Japan combined. The atrial fibrillation population treated with ablation is expected to grow with a double digit rate in these regions. The increasing prevalence of atrial fibrillation and advancement in the ablation technologies drive the use of ablation products in the treatment of atrial fibrillation. http://www.marketsandmarkets.com/Market-Reports/atrial-fibrillation-surgery-market-8998731.html

4. The European Society of Cardiology guidelines recommend use of surgical and catheter ablation procedures for the treatment of atrial fibrillation, if anti-arrhythmic drug therapy results are inadequate. Further, guidelines recommend using surgical ablation for the treatment of patients failing catheter ablation. This market is segmented, on the basis of surgical procedures, into catheter ablation and surgical ablation. Catheter ablation procedures hold the maximum share in this market and are expected to grow with the highest CAGR during forecast period of 2015 to 2020. The geographical segmentation includes North America, Europe, Asia-Pacific and RoW. North America holds the largest share in this market, both in terms of number of procedures and revenue. http://www.marketsandmarkets.com/Market-Reports/atrial-fibrillation-surgery-market-8998731.html

5. However, Asia-Pacific is expected to witness the highest growth rate owing to the presence of a large patient population, growing medical tourism, and high focus of global market players on emerging Asia-Pacific countries such as China and India. The major players in this market include Biosense Webster, Inc., St. Jude Medical, Inc., Medtronic, Inc., Boston Scientific Corporation, Articure, Inc., Cardiofocus, Inc., nContact, Inc., Cardima, Inc. and Biotronik SE & Co. http://www.marketsandmarkets.com/Market-Reports/atrial-fibrillation-surgery-market-8998731.html

6. About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.  http://www.marketsandmarkets.com/Market-Reports/atrial-fibrillation-surgery-market-8998731.html

7. Contact Us Mr. Rohan MarketsandMarkets™ 701 Pike Street Suite 2175, Seattle, WA 98101, United States Tel: 1-888-600-6441 Email: sales@marketsandmarkets.comMarketsandMarkets Bloghttp://www.marketsandmarkets.comhttp://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets